Episode 6ย  – Cornelia de Lange syndrome (CdLS): Beyond the Variant

โ€”

์ œ๊ณต

์•ˆ

๐Ÿ“Œ Series Introduction

์ด ์‹œ๋ฆฌ์ฆˆ๋Š” 3billion์˜ ์ž„์ƒ ์œ ์ „ํ•™ ์ „๋ฌธ๊ฐ€๊ฐ€ ์ง์ ‘ ์ž‘์„ฑํ•œ ๊ธ€์ž…๋‹ˆ๋‹ค. AI ๊ธฐ๋ฐ˜ ์œ ์ „๋ณ€์ด ํŒ๋… ๋„๊ตฌ๊ฐ€ ๋ณดํŽธํ™”๋œ ์‹œ๋Œ€์—, ์ž๋™ํ™”๋œ ์šฐ์„ ์ˆœ์œ„ํ™” ์ดํ›„ ํŒ๋…์ž๊ฐ€ ์‹ค์ œ๋กœ ๋ฌด์—‡์„ ์ดํ•ดํ•˜๊ณ  ์–ด๋–ป๊ฒŒ ํŒ๋‹จํ•ด์•ผ ํ•˜๋Š”์ง€์— ์ดˆ์ ์„ ๋งž์ถฅ๋‹ˆ๋‹ค.

๊ฐ ํŽธ์—์„œ๋Š” ํ•˜๋‚˜์˜ ์งˆํ™˜๊ตฐ์„ ์ค‘์‹ฌ์œผ๋กœ, ์œ ์ „์  ๊ธฐ์ „๊ณผ ์ž„์ƒ ์ŠคํŽ™ํŠธ๋Ÿผ์„ ํ•จ๊ป˜ ์‚ดํŽด๋ณด๋ฉฐ ๋ณ€์ด๋ฅผ โ€œ์ฐพ๋Š” ๊ฒƒโ€์„ ๋„˜์–ด โ€œ์„ค๋ช…ํ•˜๊ณ  ํ•ด์„ํ•˜๋Š”โ€ ๋ฐ ํ•„์š”ํ•œ ๊ด€์ ์„ ๊ณต์œ ํ•˜๊ณ ์ž ํ•ฉ๋‹ˆ๋‹ค.


Cornelia de Lange syndrome (CdLS) ์ •๋ฆฌ

Key Takeaway

CdLS๋Š” phenotype์œผ๋กœ ์˜์‹ฌํ•˜๊ณ , variant ํ•ด์„์œผ๋กœ ํ™•์ •๋˜๋Š” ์งˆํ™˜์ด๋ฉฐ, ๊ทธ ํ•ด์„์ด ์ถ•์ ๋  ๋•Œ ๋น„๋กœ์†Œ ๋ฐ˜๋ณต ๊ฐ€๋Šฅํ•œ ์ง„๋‹จ์ด ๋ฉ๋‹ˆ๋‹ค.

CdLS์™€ ๊ฐ™์€ ์งˆํ™˜์—์„œ๋Š” ๋‹จ์ˆœํžˆ variant๋ฅผ ์ฐพ๋Š” ๊ฒƒ๋ณด๋‹ค โ€œํ•ด์„์„ ์–ด๋–ป๊ฒŒ ๊ตฌ์กฐํ™”ํ•˜๊ณ  ๋‚จ๊ธฐ๋А๋ƒโ€๊ฐ€ ๋” ์ค‘์š”ํ•ฉ๋‹ˆ๋‹ค.

CdLS๋ž€ ๋ฌด์—‡์ธ๊ฐ€?

Cornelia de Lange syndrome (CdLS)๋Š” ์˜ค๋ž˜์ „๋ถ€ํ„ฐ ์•Œ๋ ค์ง„ ํฌ๊ท€ ์œ ์ „ ์งˆํ™˜์ž…๋‹ˆ๋‹ค.

1849๋…„์— ์ฒ˜์Œ ๋ณด๊ณ ๋˜์—ˆ๊ณ , 1930๋…„๋Œ€ Cornelia de Lange์— ์˜ํ•ด ์ž„์ƒ์ ์œผ๋กœ ์ •๋ฆฌ๋˜์—ˆ์Šต๋‹ˆ๋‹ค. ์ดํ›„ 2004๋…„์— NIPBL ์œ ์ „์ž๊ฐ€ ๋ฐœ๊ฒฌ๋˜๋ฉด์„œ ๋ถ„์ž์  ์›์ธ์ด ๋ฐํ˜€์กŒ์Šต๋‹ˆ๋‹ค.

๐Ÿ‘‰ ์ฆ‰, ์ž„์ƒ์ ์œผ๋กœ ๋จผ์ € ์ •์˜๋˜๊ณ  ์ดํ›„ ์œ ์ „์  ์›์ธ์ด ๋ฐํ˜€์ง„ ์งˆํ™˜์ž…๋‹ˆ๋‹ค.

์ž„์ƒ์—์„œ๋Š” ์–ด๋–ป๊ฒŒ ๋ณด์ผ๊นŒ์š”?

CdLS๋Š” ์—ฌ๋Ÿฌ ์‹œ์Šคํ…œ์— ๊ฑธ์ณ ๋‚˜ํƒ€๋‚˜๋Š” ์ „ํ˜•์ ์ธ syndromic disorder์ž…๋‹ˆ๋‹ค.

๋Œ€ํ‘œ์ ์ธ ์–ผ๊ตด ํŠน์ง•์œผ๋กœ๋Š” synophrys, hirsutism, anteverted nares๊ฐ€ ์žˆ์œผ๋ฉฐ ์ด๋Š”  CdLS๋ฅผ ์˜์‹ฌํ•˜๊ฒŒ ๋งŒ๋“œ๋Š” ์ค‘์š”ํ•œ ๋‹จ์„œ์ž…๋‹ˆ๋‹ค.

์—ฌ๊ธฐ์— ์„ฑ์žฅ ์ง€์—ฐ๊ณผ ์‹ ๊ฒฝ๋ฐœ๋‹ฌ ์ด์ƒ, ๊ทธ๋ฆฌ๊ณ  self-injurious behavior๊ฐ€ ํ•จ๊ป˜ ๋‚˜ํƒ€๋‚˜๋Š” ๊ฒฝ์šฐ๊ฐ€ ๋งŽ์Šต๋‹ˆ๋‹ค.

๋˜ํ•œ upper limb ์ด์ƒ, GERD, ์„ ์ฒœ์„ฑ ์‹ฌ์žฅ ์งˆํ™˜, ์ฒญ๋ ฅ ์ด์ƒ ๋“ฑ ๋‹ค์–‘ํ•œ ์žฅ๊ธฐ ์ด์ƒ์ด ๋™๋ฐ˜๋  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

๐Ÿ‘‰ ์ •๋ฆฌํ•˜๋ฉด CdLs์˜ ์ž„์ƒ์  ํŠน์ง•์€ ์–ผ๊ตด + ์„ฑ์žฅ/๋ฐœ๋‹ฌ + ์‚ฌ์ง€ ์ด์ƒ ์ด ์„ธ ๊ฐ€์ง€ ์ถ•์œผ๋กœ ์ดํ•ดํ•˜์‹œ๋ฉด ์ข‹์Šต๋‹ˆ๋‹ค.

๊ทธ๋Ÿฐ๋ฐ ์ด๊ฒƒ๋งŒ์œผ๋กœ ์ง„๋‹จ์ด ๊ฐ€๋Šฅํ• ๊นŒ์š”?

๊ณผ๊ฑฐ์—๋Š” ํŠน์ • ์–ผ๊ตด/์ž„์ƒ ํŠน์ง• ์ค‘์‹ฌ์œผ๋กœ ์ง„๋‹จ์ด ๋˜์—ˆ์Šต๋‹ˆ๋‹ค. 

์ด๋Ÿฐ ํŠน์ง•์ด ํ™•์ธ๋˜๋ฉด โ€œ์ด ์ •๋„๋ฉด CdLS ์•„๋‹๊นŒ?โ€๋ผ๊ณ  ์ƒ๊ฐํ–ˆ์Šต๋‹ˆ๋‹ค. 

ํ•˜์ง€๋งŒ ์‹ค์ œ ์ž„์ƒ์—์„œ๋Š” ์•„๋ž˜์™€ ๊ฐ™์€ ํŠน์ง•๋•Œ๋ฌธ์— ์ง„๋‹จ์œผ๋กœ ์—ฐ๊ฒฐ๋˜์ง€ ๋ชปํ•˜๋Š” ๊ฒฝ์šฐ๊ฐ€ ์žˆ์—ˆ์Šต๋‹ˆ๋‹ค.

  • ํ‘œํ˜„ํ˜•์ด ๋งค์šฐ ๋‹ค์–‘ํ•˜๊ณ 
  • ์ „ํ˜•์ ์ด์ง€ ์•Š์€ ์ผ€์ด์Šค๋„ ๋งŽ์œผ๋ฉฐ
  • ๋‹ค๋ฅธ ์งˆํ™˜์ฒ˜๋Ÿผ ๋ณด์ด๋Š” ๊ฒฝ์šฐ๋„ ๋งŽ์Šต๋‹ˆ๋‹ค

์œ ์ „์ž ์—ฐ๊ตฌ๊ฐ€ ์ง„ํ–‰๋˜๋ฉด์„œ CdLS๋Š”

โ— ๋ˆˆ์œผ๋กœ ๋ณด๊ณ  ํ™•์ •ํ•˜๋Š” ์งˆํ™˜์ด ์•„๋‹ˆ๋ผ
โ— ์œ ์ „ ๋ณ€์ด๊นŒ์ง€ ํ™•์ธํ•ด์•ผ ์ง„๋‹จ์ด ์™„์„ฑ๋˜๋Š” ์งˆํ™˜์ž…๋‹ˆ๋‹ค

์™œ ์ด๋ ‡๊ฒŒ ๋‹ค์–‘ํ•˜๊ฒŒ ๋ณด์ผ๊นŒ์š”?

ํ˜„์žฌ CdLS๋Š” cohesinopathy, ์ฆ‰ ์ŠคํŽ™ํŠธ๋Ÿผ ์งˆํ™˜์œผ๋กœ ์ดํ•ด๋ฉ๋‹ˆ๋‹ค.

  • ๊ฐ™์€ ์œ ์ „์ž์—์„œ๋„ ๋‹ค์–‘ํ•œ phenotype 
  • ๋‹ค๋ฅธ ์œ ์ „์ž์—์„œ๋„ ์œ ์‚ฌํ•œ phenotype ์ด ๋‚˜ํƒ€๋‚  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

๊ทธ๋ž˜์„œ Classic / Non-classic / CdLS-like๋ผ๋Š” ๊ฐœ๋…์ด ๋“ฑ์žฅํ–ˆ์Šต๋‹ˆ๋‹ค.

์งˆํ™˜์˜ ๋ณธ์งˆ์€ โ€œ์ „์‚ฌ ์กฐ์ ˆ ์ด์ƒโ€์ž…๋‹ˆ๋‹ค

CdLS์˜ ํ•ต์‹ฌ์€ cohesin ์ž์ฒด๊ฐ€ ์•„๋‹ˆ๋ผ transcription regulation์ž…๋‹ˆ๋‹ค.

  • chromatin ๊ตฌ์กฐ ๋ณ€ํ™”
  • enhancerโ€“promoter interaction ๋ถ•๊ดด
  • ์ „๋ฐ˜์ ์ธ ์œ ์ „์ž ๋ฐœํ˜„ ๋ณ€ํ™”

๐Ÿ‘‰ ๊ฒฐ๊ณผ์ ์œผ๋กœ ์ „์ฒด ๋ฐœํ˜„ ํŒจํ„ด์ด ๋ฏธ์„ธํ•˜๊ฒŒ ํํŠธ๋Ÿฌ์ง€๋Š” ์ƒํƒœ๊ฐ€ ๋ฉ๋‹ˆ๋‹ค

์ด ๋•Œ๋ฌธ์— phenotype์ด ์ผ์ •ํ•˜์ง€ ์•Š๊ฒŒ ๋‚˜ํƒ€๋‚ฉ๋‹ˆ๋‹ค.

์œ ์ „์ž๋ณ„๋กœ ๋ณด๋ฉด ์กฐ๊ธˆ ๋” ๋ช…ํ™•ํ•ด์ง‘๋‹ˆ๋‹ค

CdLS๋Š” ์—ฌ๋Ÿฌ ์œ ์ „์ž์™€ ์—ฐ๊ด€๋˜์–ด ์žˆ์œผ๋ฉฐ, ๊ฐ ์œ ์ „์ž์— ๋”ฐ๋ผ ์–ด๋А ์ •๋„ phenotype ๊ฒฝํ–ฅ์ด ๋‚˜ํƒ€๋‚ฉ๋‹ˆ๋‹ค.

๊ฐ€์žฅ ํ”ํ•œ ์›์ธ์€ NIPBL (~80%)์ž…๋‹ˆ๋‹ค. ์ฃผ๋กœ LoF ๋ณ€์ด๊ฐ€ ๋งŽ์œผ๋ฉฐ, ์ „์‚ฌ ์กฐ์ ˆ์— ํฐ ์˜ํ–ฅ์„ ์ฃผ๊ธฐ ๋•Œ๋ฌธ์— ๐Ÿ‘‰ ๋น„๊ต์  classicํ•˜๊ณ  severeํ•œ phenotype์„ ๋ณด์ด๋Š” ๊ฒฝ์šฐ๊ฐ€ ๋งŽ์Šต๋‹ˆ๋‹ค.

๋ฐ˜๋ฉด SMC1A, SMC3๋Š” cohesin ๊ตฌ์กฐ๋ฅผ ์œ ์ง€ํ•˜๋Š” ๋‹จ๋ฐฑ์งˆ๋กœ, ๋Œ€์ฒด๋กœ missense, in-frame deletions ๋ณ€์ด๊ฐ€ ๋งŽ๊ณ  ์ง€์  ์žฅ์• (ID)๋Š” ๊ด€์ฐฐ๋˜๋ฉฐ, ์ค‘๋“ฑ๋„์—์„œ ์ค‘์ฆ๊นŒ์ง€ ๋‹ค์–‘ํ•˜๊ฒŒ ๋‚˜ํƒ€๋‚ฉ๋‹ˆ๋‹ค.  ๋˜ํ•œ ๋ˆˆ์น์€ ์•ฝ๊ฐ„ ๋” ํ‰ํ‰ํ•˜๊ณ  ๋„“์€ ํ˜•ํƒœ๋ฅผ ๋ณด์ด๋ฉฐ, ์ฝง๋“ฑ์€ ๋” ๋„“๊ณ  ๊ธธ๊ฒŒ ๋‚˜ํƒ€๋‚ฉ๋‹ˆ๋‹ค.

HDAC8์˜ ๊ฒฝ์šฐ CdLS facial feature๋Š” ์œ ์ง€๋˜์ง€๋งŒ ์„ฑ์žฅ ์ง€์—ฐ์€ ์ƒ๋Œ€์ ์œผ๋กœ ์‹ฌํ•˜์ง€ ์•Š์€ ๊ฒฝ์šฐ๊ฐ€ ๋งŽ์Šต๋‹ˆ๋‹ค. ๋„“์€ ๋ˆˆ ๊ฐ„๊ฒฉ, ๋„“์€ ์ฝ”, dental anomaly, ๊ทธ๋ฆฌ๊ณ  mosaic skin pigmentation ๊ฐ™์€ ํŠน์ง•์ด ํžŒํŠธ๊ฐ€ ๋ฉ๋‹ˆ๋‹ค.

RAD21์€ ๊ตฌ์กฐ์  ์ด์ƒ์ด ๊ฑฐ์˜ ์—†๊ณ  ์ธ์ง€ ๊ธฐ๋Šฅ๋„ ๋น„๊ต์  ๋ณด์กด๋˜๋Š” ๊ฒฝ์šฐ๊ฐ€ ๋งŽ์Šต๋‹ˆ๋‹ค. ์ผ๋ถ€๋Š” ์ •์ƒ ๋ฒ”์œ„์— ๊ฐ€๊นŒ์šด ๊ฒฝ์šฐ๋„ ๋ณด๊ณ ๋ฉ๋‹ˆ๋‹ค.

๐Ÿ‘‰ ์ •๋ฆฌํ•˜๋ฉด

  • NIPBL โ†’ severe ๊ฒฝํ–ฅ
  • SMC ๊ณ„์—ด โ†’ mildโ€“moderate
  • HDAC8 โ†’ moderate
  • RAD21 โ†’ ๋งค์šฐ mild

ํ•˜์ง€๋งŒ ์ด ๊ตฌ๋ถ„์€ ์ ˆ๋Œ€์ ์ธ ๊ธฐ์ค€์ด ์•„๋‹ˆ๋ผ โ€œ๊ฒฝํ–ฅโ€์ผ ๋ฟ์ด๋ผ๋Š” ์ ์ด ์ค‘์š”ํ•ฉ๋‹ˆ๋‹ค.


๊ทธ๋ž˜์„œ ํŒ๋…์ด ์–ด๋ ค์›Œ์ง‘๋‹ˆ๋‹ค

์‹ค์ œ ์ž„์ƒ์—์„œ๋Š” ๋‹ค์Œ๊ณผ ๊ฐ™์€ ์ƒํ™ฉ์ด ์ž์ฃผ ๋ฐœ์ƒํ•ฉ๋‹ˆ๋‹ค.

  • ๊ด€๋ จ ์œ ์ „์ž์˜ variant๋Š” ํ™•์ธ
  • phenotype์ด ์• ๋งค
  • ํ™•์‹ ์ด ๋ถ€์กฑํ•œ ์ƒํƒœ

๋˜๋Š” ‘๊ฐ™์€ ๋ฐ์ดํ„ฐ๋ฅผ ๋‘๊ณ ๋„ ํŒ€๋งˆ๋‹ค ๊ฒฐ๋ก ์ด ๋‹ฌ๋ผ์ง€๋Š” ๊ฒฝ์šฐ’

ํŠนํžˆ CdLS์ฒ˜๋Ÿผ โ€œ์„ค๋ช…์ด ํ•„์š”ํ•œ ์งˆํ™˜โ€์—์„œ ์ด ๋ฌธ์ œ๊ฐ€ ๋” ํฌ๊ฒŒ ๋‚˜ํƒ€๋‚ฉ๋‹ˆ๋‹ค.

๊ฒฐ๊ตญ ๋‚จ๋Š” ์งˆ๋ฌธ ํ•˜๋‚˜

CdLS์—์„œ ๊ฐ€์žฅ ์ค‘์š”ํ•œ ์งˆ๋ฌธ์€ ์ด๊ฒƒ์ž…๋‹ˆ๋‹ค.

๐Ÿ‘‰ โ€œ์ด ๋ณ€์ด๊ฐ€ ์™œ ์ด ํ™˜์ž๋ฅผ ์„ค๋ช…ํ•˜๋Š”๊ฐ€?โ€

์ด ์งˆ๋ฌธ์— ๋‹ตํ•˜๋ ค๋ฉด ํ•ด์„ ์ž์ฒด๊ฐ€ ๊ตฌ์กฐํ™”๋˜์–ด์•ผ ํ•ฉ๋‹ˆ๋‹ค

  • phenotypeโ€“gene ์—ฐ๊ฒฐ
  • functional impact ํ•ด์„
  • differential๊ณผ์˜ ๋น„๊ต

์—ฌ๊ธฐ์„œ ๋งŽ์€ ํŒ€์ด ๋ง‰ํž™๋‹ˆ๋‹ค

๋ฌธ์ œ๋Š” ๋ณดํ†ต ์ด ๋‹จ๊ณ„์—์„œ ๋ฐœ์ƒํ•ฉ๋‹ˆ๋‹ค.

  • ํ•ด์„์€ ํ–ˆ์ง€๋งŒ ๊ธฐ๋ก์ด ๋‚จ์ง€ ์•Š๊ณ 
  • ๊ฐ™์€ variant๋ฅผ ๋งค๋ฒˆ ์ƒˆ๋กญ๊ฒŒ ํ•ด์„ํ•˜๋ฉฐ
  • ํŒ€ ๋‚ด์—์„œ๋„ ํŒ๋‹จ ๊ธฐ์ค€์ด ๋‹ฌ๋ผ์ง‘๋‹ˆ๋‹ค

๐Ÿ‘‰ ๊ฒฐ๊ณผ์ ์œผ๋กœ ํ•ด์„์€ ๊ฐœ์ธ์˜ ๊ฒฝํ—˜์— ์˜์กดํ•˜๊ฒŒ ๋ฉ๋‹ˆ๋‹ค.

ํŒ๋…์ž Tip

  • phenotype์€ ์ถœ๋ฐœ์ ์ผ ๋ฟ์ž…๋‹ˆ๋‹ค
  • ์ „ํ˜•์ ์ด์ง€ ์•Š์€ ์ผ€์ด์Šค๋ฅผ ์‰ฝ๊ฒŒ ๋ฐฐ์ œํ•˜์ง€ ๋งˆ์‹ญ์‹œ์˜ค
  • CdLS-like ์งˆํ™˜์„ ํ•ญ์ƒ ํ•จ๊ป˜ ๊ณ ๋ คํ•˜์‹ญ์‹œ์˜ค

๐Ÿ‘‰ ๊ทธ๋ฆฌ๊ณ  ๊ฐ€์žฅ ์ค‘์š”ํ•œ ๊ฒƒ: ํ•ด์„์€ ๋ฐ˜๋“œ์‹œ ๊ธฐ๋ก๋˜์–ด์•ผ ํ•ฉ๋‹ˆ๋‹ค.

ํ•œ ์ค„ ์ •๋ฆฌ

๐Ÿ‘‰ CdLS๋Š” phenotype์œผ๋กœ ์˜์‹ฌํ•˜๊ณ , variant ํ•ด์„์œผ๋กœ ํ™•์ •๋˜๋Š” ์งˆํ™˜์ด๋ฉฐ, ๊ทธ ํ•ด์„์ด ์ถ•์ ๋  ๋•Œ ๋น„๋กœ์†Œ ๋ฐ˜๋ณต ๊ฐ€๋Šฅํ•œ ์ง„๋‹จ์ด ๋ฉ๋‹ˆ๋‹ค.

์ด ๊ธ€์—์„œ ๋‹ค๋ฃฌ ๊ฒƒ์ฒ˜๋Ÿผ, CdLS์™€ ๊ฐ™์€ ์งˆํ™˜์—์„œ๋Š” ๋‹จ์ˆœํžˆ variant๋ฅผ ์ฐพ๋Š” ๊ฒƒ๋ณด๋‹ค โ€œํ•ด์„์„ ์–ด๋–ป๊ฒŒ ๊ตฌ์กฐํ™”ํ•˜๊ณ  ๋‚จ๊ธฐ๋А๋ƒโ€๊ฐ€ ๋” ์ค‘์š”ํ•ฉ๋‹ˆ๋‹ค.


๐Ÿ’ก ํ˜น์‹œ โ€œ์ด๋Ÿฐ ์ผ€์ด์Šค๋“ค์„ ์ข€ ๋” ๊ตฌ์กฐ์ ์œผ๋กœ ํ’€ ์ˆ˜๋Š” ์—†์„๊นŒ?โ€๋ผ๋Š” ์ƒ๊ฐ์ด ๋“ค์—ˆ๋‹ค๋ฉด? 

GEBRA๋Š”

  • phenotypeโ€“variant ์—ฐ๊ฒฐ
  • ํ•ด์„ ๊ทผ๊ฑฐ ๊ธฐ๋ก
  • ๋ฐ˜๋ณต ๊ฐ€๋Šฅํ•œ interpretation workflow

๋ฅผ ํ†ตํ•ด ํŒ๋… ๊ณผ์ •์„ ๋” ๋น ๋ฅด๊ณ  ์ผ๊ด€๋˜๊ฒŒ ๋งŒ๋“œ๋Š” ๊ฒƒ์„ ๋ชฉํ‘œ๋กœ ํ•ฉ๋‹ˆ๋‹ค.

References

  • Parenti I, Kaiser FJ. Cornelia de Lange syndrome as paradigm of chromatinopathies. Front Neurosci. 2021;15:774950. doi:10.3389/fnins.2021.774950
  • Deardorff MA, Noon SE, Krantz ID. Cornelia de Lange syndrome. In: Adam MP, Bick S, Mirzaa GM, et al., editors. GeneReviewsยฎ [Internet]. Seattle (WA): University of Washington, Seattle; 1993โ€“2026 [updated 2020 Oct 15]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1104/
    Sarogni P, Pallotta MM, Musio A. Cornelia de Lange syndrome: from molecular diagnosis to therapeutic approach. J Med Genet. 2020;57(5):289โ€“295. doi:10.1136/jmedgenet-2019-106277
  • Minor A, Shinawi M, Hogue JS, Vineyard M, Hamlin DR, Tan C, Donato K, Wysinger L, Botes S, Das S, Del Gaudio D. Two novel RAD21 mutations in patients with mild Cornelia de Lange syndrome-like presentation and report of the first familial case. Gene. 2014;537(2):279โ€“284. doi:10.1016/j.gene.2013.12.045
  • Santen GW, Aten E, Sun Y, Almomani R, Gilissen C, Nielsen M, Kant SG, Snoeck IN, Peeters EA, Hilhorst-Hofstee Y, Wessels MW, den Hollander NS, Ruivenkamp CA, van Ommen GJ, Breuning MH, den Dunnen JT, van Haeringen A, Kriek M. Mutations in SWI/SNF chromatin remodeling complex gene ARID1B cause Coffin-Siris syndrome. Nat Genet. 2012;44(4):379โ€“380. doi:10.1038/ng.2217
  • Raible SE, Mehta D, Bettale C, Fiordaliso S, Kaur M, Medne L, Rio M, Haan E, White SM, Cusmano-Ozog K, Nishi E, Guo Y, Wu H, Shi X, Zhao Q, Zhang X, Lei Q, Lu A, He X, Okamoto N, Miyake N, Piccione J, Allen J, Matsumoto N, Pipan M, Krantz ID, Izumi K. Clinical and molecular spectrum of CHOPS syndrome. Am J Med Genet A. 2019;179(7):1126โ€“1138. doi:10.1002/ajmg.a.61174


์ฝ”๋ฉ˜ํŠธ

๋‹ต๊ธ€ ๋‚จ๊ธฐ๊ธฐ